Literature DB >> 7007051

Skeletal uptake of diphosphonate: a review.

I Fogelman.   

Abstract

The diphosphonates are currently the skeletal imaging agents of choice and while extremely sensitive for bony abnormality their mechanism of action remains poorly understood. The current concepts in bone uptake mechanisms are reviewed and it is concluded that diphosphonate uptake is most likely related to sites of newly forming bone with diphosphonate adsorbed onto the surface of hydroxyapatite crystals. In situations where there is markedly increased skeletal uptake of tracer, increased vascularity alone cannot account for changes in tracer uptake and changes in skeletal extraction, related to newly forming bone are more important.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7007051     DOI: 10.1007/bf00252034

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  36 in total

Review 1.  Bone scanning: radionuclidic reaction mechanisms.

Authors:  A G Jones; M D Francis; M A Davis
Journal:  Semin Nucl Med       Date:  1976-01       Impact factor: 4.446

2.  Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy.

Authors:  W M Sy; A K Mittal
Journal:  Br J Radiol       Date:  1975-11       Impact factor: 3.039

3.  Technetium-99m-pyrophosphate kinetics and imaging in metabolic bone disease.

Authors:  L Rosenthall; M Kaye
Journal:  J Nucl Med       Date:  1975-01       Impact factor: 10.057

4.  99m Tc-polyphosphate: histological localization in human femurs by autoradiography.

Authors:  R L Tilden; J Jackson; W F Enneking; F H DeLand; J T McVey
Journal:  J Nucl Med       Date:  1973-08       Impact factor: 10.057

5.  Mechanisms of skeletal tracer uptake.

Authors:  N D Charkes
Journal:  J Nucl Med       Date:  1979-07       Impact factor: 10.057

6.  Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans.

Authors:  A J Tofe; M D Francis; W J Harvey
Journal:  J Nucl Med       Date:  1975-11       Impact factor: 10.057

7.  Bone scan appearance of a Paget's osteosarcoma: failure to concentrate HEDP.

Authors:  J H McKillop; I Fogelman; I T Boyle; W R Greig
Journal:  J Nucl Med       Date:  1977-10       Impact factor: 10.057

8.  The role of bone scanning in osteomalacia.

Authors:  I Fogelman; J H McKillop; R G Bessent; I T Boyle; J G Turner; W R Greig
Journal:  J Nucl Med       Date:  1978-03       Impact factor: 10.057

9.  Studies of skeletal tracer kinetics. I. Digital-computer solution of a five-compartment model of [18F] fluoride kinetics in humans.

Authors:  N D Charkes; P T Makler; C Philips
Journal:  J Nucl Med       Date:  1978-12       Impact factor: 10.057

10.  Bone extraction and blood clearance of diphosphonate in the dog.

Authors:  S P Hughes; D R Davies; J B Bassingthwaighte; F G Knox; P J Kelly
Journal:  Am J Physiol       Date:  1977-03
View more
  19 in total

1.  FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy.

Authors:  Ora Israel; Anat Goldberg; Alicia Nachtigal; Daniela Militianu; Rachel Bar-Shalom; Zohar Keidar; Ignac Fogelman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-22       Impact factor: 9.236

2.  [68Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients.

Authors:  Jan-Carlo Janssen; Nadine Woythal; Sebastian Meißner; Vikas Prasad; Winfried Brenner; Gerd Diederichs; Bernd Hamm; Marcus R Makowski
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

3.  (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.

Authors:  M Beheshti; F M Mottaghy; F Paycha; F F F Behrendt; T Van den Wyngaert; I Fogelman; K Strobel; M Celli; S Fanti; F Giammarile; B Krause; W Langsteger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-23       Impact factor: 9.236

4.  Comparison of facet joint activity on 99mTc-MDP SPECT/CT with facet joint signal change on MRI with fat suppression.

Authors:  Vance T Lehman; Robert C Murphy; Louis A Schenck; Rickey E Carter; Geoffrey B Johnson; Amy L Kotsenas; Jonathan M Morris; Mark A Nathan; John T Wald; Timothy P Maus
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

5.  99mTc-MDP retention in osteoporosis: relationship to other indices of bone cell activity and response to calcium and vitamin D therapy.

Authors:  M W Davie; J M Britton; M Haddaway; I W McCall
Journal:  Eur J Nucl Med       Date:  1987

6.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors:  R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

7.  Factor analysis as a means of determining response to chemotherapy in patients with osteogenic sarcoma.

Authors:  V Edeline; F Frouin; J P Bazin; M Di Paola; C Kalifa; G Contesso; C Parmentier; J Lumbroso; R Di Paola
Journal:  Eur J Nucl Med       Date:  1993-12

8.  Technetium-1,2-dihydroxy-1,2-bis(dihydroxyphosphinyl)ethane (99mTc-DHPE). A promising new skeletal imaging agent.

Authors:  S C Archimandritis; A K Tsolis
Journal:  Eur J Nucl Med       Date:  1987

9.  Determination of bone turnover by urinary excretion of 99mTc-MDP.

Authors:  K Thomsen; L Nilas; T Mogensen; C Christiansen
Journal:  Eur J Nucl Med       Date:  1986

Review 10.  Bisphosphonates and the treatment of bone disease in the elderly.

Authors:  A Johansen; M Stone; F Rawlinson
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.